The state of New York currently has 6 active clinical trials seeking participants for Insomnia research studies. These trials are conducted in various cities, including New York, Rochester, Bronx and Buffalo.
Digital CBT for Insomnia and Depression
Recruiting
This study has two primary objectives, each of which addresses critical clinical and research gaps for individuals who have co-occurring insomnia and depression. The first objective is to address whether sequential treatment of insomnia and depression is superior to a single treatment for either depression or for insomnia, and if so, which treatment sequence is optimal. The second objective is to determine if there are heterogeneity of treatment effects; that is, variation in which interventions... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
05/20/2024
Locations: University of Rochester Sleep Research Laboratory, Rochester, New York
Conditions: Depression, Insomnia
Efficacy of Suvorexant on Post-operative Sleep Disturbance
Recruiting
The study is a parallel group, double blind, randomized trial. Subjects will be recruited from individuals undergoing elective surgery for orthopedic, abdominal, urologic, gynecologic or spine reasons. Out of 92 subjects, one experimental group of 46 subjects will receive 20 mg Suvorexant beginning the first in-hospital night ("day 0") and continuing for their hospital stay. If the dose is not well tolerated (e.g., daytime sleepiness), then the dose may be decreased to 10 mg of Suvorexant. For... Read More
Gender:
All
Ages:
Between 50 years and 90 years
Trial Updated:
05/20/2024
Locations: NewYork-Presbyterian Allen Hospital/CUMC Milstein Hospital Building, New York, New York
Conditions: Postoperative Insomnia, Postoperative Delirium
Brief Versus Standard Cognitive Behavioral Therapy for Insomnia in Veterans
Recruiting
Insomnia is a common condition in Veterans, with prevalence rates as high as 53% among treatment-seeking Veterans. Chronic untreated insomnia is associated with increased risk for functional impairment, psychiatric illness, suicidal ideation, unhealthy lifestyles, and decreased quality of life. Cognitive-Behavioral Therapy for Insomnia (CBT-I) is recognized as the first-line treatment for insomnia. Despite its proven efficacy, CBT-I is not always readily provided and/or accessible to Veterans. T... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
05/02/2024
Locations: VA Finger Lakes Healthcare System, Canandaigua, NY, Canandaigua, New York
Conditions: Insomnia
Adapting CBT-I for Hazardous Alcohol Users
Recruiting
The goal of this intervention development trial is to develop, refine, and test a telephone-delivered, 4-session version of cognitive behavioral therapy for insomnia adapted to hazardous alcohol users with co-occurring insomnia. The project will begin with a small, open label pilot to refine the intervention and proceed to a small, randomized trial comparing the intervention to a sleep and alcohol education control condition. The two main questions it aims to answer are whether the intervention... Read More
Gender:
All
Ages:
Between 25 years and 64 years
Trial Updated:
04/02/2024
Locations: University of Rochester Medical Center, Rochester, New York
Conditions: Insomnia, Harmful; Use, Alcohol
Suvorexant and Sleep/Delirium in ICU Patients
Recruiting
Investigators will evaluate the efficacy of postoperative oral suvorexant treatment on nighttime wakefulness after persistent sleep onset (WASO) among adult cardiac surgical patients recovering in the cardiac intensive care unit (ICU). The study include patients ≥ 60 years old undergoing coronary artery bypass graft surgery (CABG), with or without valve surgery (aortic or mitral). Patients will receive either oral suvorexant or placebo for 7 nights starting the night after extubation. The primar... Read More
Gender:
All
Ages:
60 years and above
Trial Updated:
11/15/2023
Locations: Montefiore Medical Center/Albert Einstein college of Medicine, Bronx, New York
Conditions: Insomnia, Sleep Fragmentation, Sleep Initiation and Maintenance Disorders, Postoperative Delirium
M-Health Administered Sleep Treatment to Enhance Recovery in Bariatric Populations (MASTER)
Recruiting
This study is a longitudinal clinical trial designed to assess the feasibility of sleep intervention (Cognitive Behavioral Therapy for Insomnia (CBT-I)) in individuals with insomnia following bariatric surgery.
Gender:
All
Ages:
Between 18 years and 64 years
Trial Updated:
03/15/2021
Locations: Stony Brook University, Stony Brook, New York
Conditions: Insomnia, Morbid Obesity